Sztuka inwestowania

Available treatments for Alzheimer's disease include medications such as cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and NMDA receptor antagonists (memantine). These drugs aim to manage symptoms by regulating neurotransmitters in the brain. Additionally, non-pharmacological interventions like cognitive stimulation therapy and physical exercise may help improve cognitive function and quality of life. Emerging treatments such as monoclonal antibodies targeting beta-amyloid plaques and tau protein tangles are under investigation. The cerebrolysin 10ml, a neurotrophic peptide mixture, has shown potential in some studies for improving cognitive function and neuroprotection. However, more research is needed to fully understand its efficacy and safety in treating Alzheimer's disease.